
UBS Gala at LSO St Luke's

LSO Premiere logos

Event at Lancaster House
LSO Premier
LSO Premier is a top-level client entertaining and business networking forum, offering corporate members a high calibre international events programme, aligned with world-class performances by the LSO.
The event format allows significant client networking opportunity with a spectacular LSO recital as centrepiece of the evening.
'LSO Premier events consistently deliver an excellent experience for our clients who are always keen to return to a special evening with the LSO, whether that be in London or other major cities.'
Gary Senior, Managing Partner Baker & McKenzie LLP
Previous events have included receptions at the Bank of England, hosted by Governor, Mervyn King, and at Ambassadors’ residences in Tokyo, New York, Paris and in exclusive London venues such as the Gherkin and Lancaster House.
With over 60 international concerts annually, residencies in New York, Paris and Aix-en-Provence, and regular concerts in Tokyo and Europe, LSO Premier provides unparalleled hospitality and networking opportunities in London and around the world.
Members also have the opportunity to host an annual event around one of the LSO’s internationally-renowned concerts with benefits including a reception for up to 50 clients and guests at the Barbican.
This forum is offered to a limited number of companies to ensure an exclusive experience for members and clients.
LSO Premier – London
£20,000 + VAT per annum
LSO Premier – International
£30,000 + VAT per annum
LSO Premier – Concert Sponsor
£20,000 + VAT per annum
(plus LSO Premier London or International membership)
For further information about corporate membership with the LSO please contact Anna-Maria Huhnt, Corporate Partnerships Manager, on 020 7382 2511, or email Anna-Maria Huhnt.
Thank you
Thank you to our current LSO Premier members for their ongoing generosity and support:
AXA Investment Managers
AXA PPP Healthcare
Baker & McKenzie LLP
Bank of America Merrill Lynch
Canon Europe
Moore Group
Oliver Wyman
PwC
Takeda Pharmaceutical Company Limited






